Hansoh Pharmaceutical to raise nearly HK$4 billion through share sale, Bloomberg says

Hansoh Pharmaceutical (3692) is said to have planned to raise nearly HK$4 billion through share sale at a discount of up to 6.5 percent.

The Chinese drugmaker intends to issue 108 million shares to raise between HK$3.92 billion and HK$3.98 billion, Bloomberg reported, citing the terms sheet. 

The shares will be sold for HK$36.3 to HK$36.88 apiece, representing a discount of between 5 percent and 6.5 percent to the closing price on Tuesday.